Back to Search
Start Over
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use data.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2020 Feb; Vol. 61 (2), pp. 491-493. Date of Electronic Publication: 2019 Oct 03. - Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 61
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Editorial & Opinion
- Accession number :
- 31580171
- Full Text :
- https://doi.org/10.1080/10428194.2019.1672057